JP2022180664A - ウェアラブル装置を利用した甲状腺機能亢進症の予測システム及び予測コンピュータプログラム - Google Patents
ウェアラブル装置を利用した甲状腺機能亢進症の予測システム及び予測コンピュータプログラム Download PDFInfo
- Publication number
- JP2022180664A JP2022180664A JP2022162722A JP2022162722A JP2022180664A JP 2022180664 A JP2022180664 A JP 2022180664A JP 2022162722 A JP2022162722 A JP 2022162722A JP 2022162722 A JP2022162722 A JP 2022162722A JP 2022180664 A JP2022180664 A JP 2022180664A
- Authority
- JP
- Japan
- Prior art keywords
- heart rate
- person
- consecutive days
- resting
- wearable device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title abstract description 50
- 238000004590 computer program Methods 0.000 title abstract description 8
- 230000000284 resting effect Effects 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims description 17
- 210000001685 thyroid gland Anatomy 0.000 claims description 8
- 239000003200 antithyroid agent Substances 0.000 claims description 6
- 229940043671 antithyroid preparations Drugs 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000009534 blood test Methods 0.000 claims description 3
- 238000002651 drug therapy Methods 0.000 claims description 2
- 230000016507 interphase Effects 0.000 claims 2
- 241000736355 Euthyroides Species 0.000 claims 1
- 230000005856 abnormality Effects 0.000 claims 1
- 238000004891 communication Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 9
- 239000005495 thyroid hormone Substances 0.000 description 9
- 229940036555 thyroid hormone Drugs 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000012545 processing Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000002618 waking effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 208000023328 Basedow disease Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000015023 Graves' disease Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- HIGRAKVNKLCVCA-UHFFFAOYSA-N alumine Chemical compound C1=CC=[Al]C=C1 HIGRAKVNKLCVCA-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 208000005057 thyrotoxicosis Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0024—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system for multiple sensor units attached to the patient, e.g. using a body or personal area network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1118—Determining activity level
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4227—Evaluating particular parts, e.g. particular organs endocrine glands, i.e. thyroid, adrenals, hypothalamic, pituitary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
- A61B5/721—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4809—Sleep detection, i.e. determining whether a subject is asleep or not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Signal Processing (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Computer Networks & Wireless Communication (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pulmonology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
央値の中央値を休止期心拍数と定義する。
休止期心拍数=[A×(起床区間に対する区間別中央値の中央値)+B×(睡眠区間に対する区間別中央値の中央値)]/(A+B)
(ただし、0<A<B)
一方、基準心拍数は、患者が正常状態の際(つまり、甲状腺機能が正常の際)に所定日数の間に測定された休止期心拍数の平均値と定義される。
Claims (8)
- 潜在的な甲状腺異常のアラートを提供する方法であって、
人の心拍数及び動きを含むデータを提供するために、人が着用しているウェアラブル装置を使用して、前記人の心拍数及び動きを取得することと、
人の甲状腺機能が正常の第1セットの連続した日に前記ウェアラブル装置によって取得されたデータを使用して、前記人の第1休止期心拍数を計算することと、
第2セットの連続した日に前記ウェアラブル装置によって取得されたデータを使用して、前記人の第2休止期心拍数を計算することと、
前記第2休止期心拍数が前記第1休止期心拍数よりも所定値以上大きい場合、前記人にアラートを出力することと、 を含み、
前記第1休止期心拍数は、前記第1セットの連続した日に取得されたデータを使用して計算され、前記第1セットの連続した日において、前記人のフリー(free)T4を測定することで、前記人の甲状腺機能が正常であることが確認され、
前記第2休止期心拍数は、前記人が医療施設を訪れることなく前記第2セットの連続した日に取得されたデータを使用して計算される、ことを特徴とする方法。 - 前記アラートは、前記人に血液検査を受けるように提案する、ことを特徴とする請求項1に記載の方法。
- 前記第1セットの連続した日は、所定数の連続した日である、ことを特徴とする請求項1に記載の方法。
- 前記第2セットの連続した日は、所定数の連続した日である、ことを特徴とする請求項1に記載の方法。
- 前記第1休止期心拍数を計算することは、前記第1セットの連続した日に前記人が動いていない時間区間を識別することと、識別された時間区間の各々の心拍数値を取得することとを含み、
前記第2休止期心拍数を計算することは、前記第2セットの連続した日に前記人が動いていない時間区間を識別することと、識別された時間区間の各々の心拍数値を取得することとを含む、ことを特徴とする請求項1に記載の方法。 - 前記第1休止期心拍数を計算することは、前記第1セットの連続した日に前記人が動いていない時間区間を識別することと、識別された時間区間の各々の心拍数値を取得することとを含み、
前記心拍数値は、前記識別された時間区間の各々の心拍数の中央値であり、
前記第1休止期心拍数は、前記識別された時間区間の心拍数値の中央値又は平均値である、ことを特徴とする請求項1に記載の方法。 - 前記第2休止期心拍数を計算することは、前記第2セットの連続した日に前記人が動いていない時間区間を識別することと、識別された時間区間の各々の心拍数値を取得することとを含み、
前記心拍数値は、前記識別された時間区間の各々の心拍数の中央値であり、
前記第2休止期心拍数は、前記識別された時間区間の心拍数値の中央値又は平均値である、ことを特徴とする請求項1に記載の方法。 - 前記第1休止期心拍数は、前記第1セットの連続した日に取得されたデータを使用して計算され、前記第1セットの連続した日において、前記人が時間の経過とともにフリー(free)T4を減少する抗甲状腺薬治療を受けている間に、前記人のフリー(free)T4を測定することで、前記人の甲状腺機能が正常であることが確認される、ことを特徴とする請求項1に記載の方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170119326A KR102033696B1 (ko) | 2017-09-18 | 2017-09-18 | 웨어러블 장치를 이용한 갑상선기능항진증의 예측 시스템 및 예측 컴퓨터프로그램 |
KR10-2017-0119326 | 2017-09-18 | ||
PCT/KR2017/011892 WO2019054553A1 (ko) | 2017-09-18 | 2017-10-26 | 웨어러블 장치를 이용한 갑상선기능항진증의 예측 시스템 및 예측 컴퓨터프로그램 |
JP2020537119A JP7399092B2 (ja) | 2017-09-18 | 2017-10-26 | 潜在的な甲状腺異常のアラートを提供する方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020537119A Division JP7399092B2 (ja) | 2017-09-18 | 2017-10-26 | 潜在的な甲状腺異常のアラートを提供する方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2022180664A true JP2022180664A (ja) | 2022-12-06 |
Family
ID=65723716
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020537119A Active JP7399092B2 (ja) | 2017-09-18 | 2017-10-26 | 潜在的な甲状腺異常のアラートを提供する方法 |
JP2022162722A Pending JP2022180664A (ja) | 2017-09-18 | 2022-10-07 | ウェアラブル装置を利用した甲状腺機能亢進症の予測システム及び予測コンピュータプログラム |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020537119A Active JP7399092B2 (ja) | 2017-09-18 | 2017-10-26 | 潜在的な甲状腺異常のアラートを提供する方法 |
Country Status (7)
Country | Link |
---|---|
US (4) | US20200214644A1 (ja) |
EP (1) | EP3685735B1 (ja) |
JP (2) | JP7399092B2 (ja) |
KR (1) | KR102033696B1 (ja) |
CN (1) | CN111372506B (ja) |
ES (1) | ES2972578T3 (ja) |
WO (1) | WO2019054553A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016077489A1 (en) * | 2014-11-11 | 2016-05-19 | Innovaura Corporation | Heart rate monitor |
KR102469743B1 (ko) | 2020-06-10 | 2022-11-22 | 주식회사 타이로스코프 | 약물 복용에 따른 갑상선 기능 모니터링 방법, 이를 수행하는 모니터링 서버 및 사용자 단말 |
CN114680856A (zh) * | 2020-12-30 | 2022-07-01 | 王励 | 状态信息确定方法及装置、控制方法及装置 |
CN114680857A (zh) * | 2020-12-30 | 2022-07-01 | 王励 | 参数确定方法、参数确定装置、存储介质及电子设备 |
KR102674339B1 (ko) * | 2021-07-29 | 2024-06-12 | 주식회사 타이로스코프 | 대상에 대한 갑상선기능이상증의 예측방법 및 시스템 |
KR20240029727A (ko) * | 2021-07-29 | 2024-03-06 | 주식회사 타이로스코프 | 대상에 대한 갑상선기능이상증의 예측방법 및 시스템 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11290282A (ja) * | 1998-04-08 | 1999-10-26 | Nec Corp | 患者監視システム及び監視方法 |
JP2011147509A (ja) | 2010-01-19 | 2011-08-04 | Parama Tec:Kk | 心電計ないしは心拍計と歩数計とを備えた複合装置 |
US20150057512A1 (en) * | 2011-11-16 | 2015-02-26 | Rijuven Corporation | Wearable heart failure monitor patch |
US9005129B2 (en) | 2012-06-22 | 2015-04-14 | Fitbit, Inc. | Wearable heart rate monitor |
US8948832B2 (en) | 2012-06-22 | 2015-02-03 | Fitbit, Inc. | Wearable heart rate monitor |
US10318708B2 (en) | 2013-03-14 | 2019-06-11 | Nike, Inc. | System and method for monitoring athletic activity from multiple body locations |
US20150094545A1 (en) * | 2013-10-01 | 2015-04-02 | Covidien Lp | Automated at-rest status sensing |
JP2015131049A (ja) * | 2014-01-15 | 2015-07-23 | セイコーエプソン株式会社 | 生体情報処理システム、電子機器及びサーバーシステム |
KR102309289B1 (ko) * | 2014-06-11 | 2021-10-06 | 엘지전자 주식회사 | 와치형 이동 단말기 |
CN106456024A (zh) * | 2014-06-12 | 2017-02-22 | 皇家飞利浦有限公司 | 静息心率监测器系统 |
SG11201704055YA (en) * | 2014-11-18 | 2017-06-29 | Univ Nanyang Tech | Server apparatus and wearable device for blood glucose monitoring and associated methods |
US20160188817A1 (en) * | 2014-12-30 | 2016-06-30 | Core Mobile Networks, Inc. | Real-Time Activity Coordination |
KR20170002035A (ko) | 2015-06-29 | 2017-01-06 | 엘지전자 주식회사 | 휴대용 기기 및 그의 체력 평가 방법 |
KR101821858B1 (ko) | 2015-08-07 | 2018-01-24 | 엘지전자 주식회사 | 휴식 심박동 측정 방법 |
CN105326493A (zh) | 2015-11-05 | 2016-02-17 | 深圳市冠旭电子有限公司 | 一种基于可穿戴电子设备的心率监测方法及系统 |
JP2017113191A (ja) | 2015-12-22 | 2017-06-29 | 富士通株式会社 | 電子機器及び脈拍数算出プログラム |
CN105708440A (zh) | 2016-03-31 | 2016-06-29 | 深圳还是威健康科技有限公司 | 一种静息心率测量方法和终端 |
CN106037749A (zh) * | 2016-05-18 | 2016-10-26 | 武汉大学 | 一种基于智能手机和可穿戴式设备的老年人跌倒监测方法 |
US10335047B2 (en) * | 2016-08-02 | 2019-07-02 | Medtronic, Inc. | Automatic heart rate diagnostics |
CN106419848A (zh) * | 2016-10-21 | 2017-02-22 | 北京通和堂生物科技有限公司 | 一种监测甲状腺机能的装置及方法 |
US10111615B2 (en) * | 2017-03-11 | 2018-10-30 | Fitbit, Inc. | Sleep scoring based on physiological information |
-
2017
- 2017-09-18 KR KR1020170119326A patent/KR102033696B1/ko active IP Right Grant
- 2017-10-26 CN CN201780096974.6A patent/CN111372506B/zh active Active
- 2017-10-26 WO PCT/KR2017/011892 patent/WO2019054553A1/ko unknown
- 2017-10-26 EP EP17924788.7A patent/EP3685735B1/en active Active
- 2017-10-26 ES ES17924788T patent/ES2972578T3/es active Active
- 2017-10-26 JP JP2020537119A patent/JP7399092B2/ja active Active
- 2017-10-26 US US16/647,963 patent/US20200214644A1/en not_active Abandoned
-
2021
- 2021-05-10 US US17/316,040 patent/US11571170B2/en active Active
-
2022
- 2022-10-07 JP JP2022162722A patent/JP2022180664A/ja active Pending
- 2022-12-30 US US18/091,751 patent/US11903743B2/en active Active
-
2024
- 2024-01-16 US US18/414,154 patent/US20240148339A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11903743B2 (en) | 2024-02-20 |
EP3685735C0 (en) | 2023-12-06 |
EP3685735B1 (en) | 2023-12-06 |
WO2019054553A1 (ko) | 2019-03-21 |
KR20190032668A (ko) | 2019-03-28 |
JP7399092B2 (ja) | 2023-12-15 |
US20210307702A1 (en) | 2021-10-07 |
KR102033696B1 (ko) | 2019-10-21 |
US20200214644A1 (en) | 2020-07-09 |
ES2972578T3 (es) | 2024-06-13 |
CN111372506A (zh) | 2020-07-03 |
US11571170B2 (en) | 2023-02-07 |
EP3685735A4 (en) | 2021-10-13 |
US20240148339A1 (en) | 2024-05-09 |
CN111372506B (zh) | 2024-01-12 |
EP3685735A1 (en) | 2020-07-29 |
JP2020534125A (ja) | 2020-11-26 |
US20230144161A1 (en) | 2023-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022180664A (ja) | ウェアラブル装置を利用した甲状腺機能亢進症の予測システム及び予測コンピュータプログラム | |
US20210169357A1 (en) | System and method for using integrated sensor arrays to measure and analyze multiple biosignatures in real time | |
US20210401314A1 (en) | Illness Detection Based on Nervous System Metrics | |
US20200359913A1 (en) | System, apparatus, and methods for remote health monitoring | |
Moser et al. | Personal health monitoring using a smartphone | |
CN111386067A (zh) | 用于监视炎症性肠病状态的系统 | |
CN116209385A (zh) | 用于心力衰竭患者的治疗性管理的组合物和方法 | |
US11937936B2 (en) | Thyroid function monitoring method according to medication, and monitoring server and user terminal performing the same | |
US20220351852A1 (en) | System, apparatus, and methods for health monitoring | |
US20210065856A1 (en) | Patient management based on sensed inputs | |
Tan et al. | Remote patient monitoring system | |
US20240225525A1 (en) | Thyroid function monitoring method according to medication, and monitoring server and user terminal performing the same | |
AU2021104542A4 (en) | I-Health-Care: Technologies Towards 5G Network for Intelligent Health-Care Using IoT Notification with Machine Learning Programming | |
US20220409187A1 (en) | Illness detection with menstrual cycle pattern analysis | |
WO2018033546A1 (en) | Blood-pressure management | |
Gopi et al. | Elderly People Health Care Monitoring System Using Internet of Things (IOT) For Exploratory Data Analysis | |
Anand et al. | Remote Patient Monitoring: An Overview of Technologies, Applications, and Challenges | |
Georga et al. | mHealth environments for chronic disease management | |
JP2020109616A (ja) | 健康状態判定システム、健康状態判定方法及びプログラム | |
Anand et al. | 13 Remote Patient Monitoring | |
WO2022198058A1 (en) | System, apparatus, and methods for health monitoring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221104 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221104 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230919 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231024 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240123 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240321 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240611 |